Artículo especial
Anticuerpos antifosfolipídicos y fracaso implantatorio recurrente en fertilización in vitro. El debate continúa
Antiphospholipid antibodies and recurrent implantation failure in in-vitro fertilization. The debate goes on
a Unidad de Alto Riesgo Obstétrico, Servicio de Obstetricia, Hospital Universitario Vall d’Hebron, Universitat Autónoma de Barcelona, Barcelona, España
b Servicio de Medicina Interna-Enfermedades Autoinmunes Sistémicas, Hospital Universitario Vall d’Hebron, Departamento de Medicina, Facultad de Medicina, Universitat Autónoma de Barcelona, Barcelona, España
Leído
4083
Vecesse ha leído el artículo
2773
Total PDF
1310
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 12 | 12 |
| 2025 11 | 0 | 34 | 34 |
| 2025 10 | 0 | 7 | 7 |
| 2025 9 | 0 | 7 | 7 |
| 2025 8 | 0 | 7 | 7 |
| 2025 7 | 0 | 4 | 4 |
| 2025 6 | 0 | 1 | 1 |
| 2025 5 | 0 | 6 | 6 |
| 2025 4 | 0 | 12 | 12 |
| 2025 3 | 0 | 16 | 16 |
| 2025 2 | 0 | 8 | 8 |
| 2025 1 | 0 | 2 | 2 |
| 2024 12 | 0 | 8 | 8 |
| 2024 11 | 0 | 4 | 4 |
| 2024 10 | 0 | 30 | 30 |
| 2024 9 | 0 | 21 | 21 |
| 2024 8 | 0 | 20 | 20 |
| 2024 7 | 0 | 44 | 44 |
| 2024 6 | 0 | 46 | 46 |
| 2024 5 | 0 | 34 | 34 |
| 2024 4 | 0 | 41 | 41 |
| 2024 3 | 0 | 60 | 60 |
| 2024 2 | 1 | 40 | 41 |
| 2024 1 | 0 | 59 | 59 |
| 2023 12 | 0 | 92 | 92 |
| 2023 11 | 0 | 123 | 123 |
| 2023 10 | 0 | 94 | 94 |
| 2023 9 | 0 | 42 | 42 |
| 2023 8 | 0 | 50 | 50 |
| 2023 7 | 0 | 77 | 77 |
| 2023 6 | 0 | 84 | 84 |
| 2023 5 | 0 | 40 | 40 |
| 2023 4 | 0 | 36 | 36 |
| 2023 3 | 1 | 44 | 45 |
| 2023 2 | 0 | 41 | 41 |
| 2022 1 | 0 | 26 | 26 |
| 2022 12 | 0 | 31 | 31 |
| 2022 11 | 0 | 64 | 64 |
| 2022 10 | 0 | 44 | 44 |
| 2022 9 | 0 | 87 | 87 |
| 2022 8 | 0 | 54 | 54 |
| 2022 7 | 0 | 34 | 34 |
| 2022 6 | 0 | 19 | 19 |
| 2022 5 | 0 | 28 | 28 |
| 2022 4 | 0 | 22 | 22 |
| 2022 3 | 0 | 32 | 32 |
| 2022 2 | 0 | 16 | 16 |
| 2021 1 | 0 | 30 | 30 |
| 2021 12 | 0 | 21 | 21 |
| 2021 11 | 0 | 36 | 36 |
| 2021 10 | 0 | 20 | 20 |
| 2021 9 | 0 | 15 | 15 |
| 2021 8 | 0 | 21 | 21 |
| 2021 7 | 0 | 14 | 14 |
| 2021 6 | 0 | 6 | 6 |
| 2021 5 | 0 | 6 | 6 |
| 2021 4 | 0 | 6 | 6 |
| 2021 3 | 0 | 3 | 3 |
| 2021 2 | 0 | 9 | 9 |
| 2020 1 | 0 | 10 | 10 |
| 2020 12 | 0 | 9 | 9 |
| 2020 11 | 0 | 13 | 13 |
| 2020 10 | 0 | 8 | 8 |
| 2020 9 | 0 | 10 | 10 |
| 2020 8 | 0 | 13 | 13 |
| 2020 7 | 0 | 5 | 5 |
| 2020 6 | 0 | 8 | 8 |
| 2020 5 | 0 | 16 | 16 |
| 2020 4 | 0 | 9 | 9 |
| 2020 3 | 0 | 19 | 19 |
| 2020 2 | 0 | 15 | 15 |
| 2020 1 | 0 | 27 | 27 |
| 2019 12 | 0 | 23 | 23 |
| 2019 11 | 0 | 4 | 4 |
| 2019 10 | 0 | 3 | 3 |
| 2019 9 | 0 | 12 | 12 |
| 2019 8 | 0 | 14 | 14 |
| 2019 7 | 0 | 22 | 22 |
| 2019 6 | 0 | 34 | 34 |
| 2019 5 | 0 | 128 | 128 |
| 2019 4 | 0 | 28 | 28 |
| 2019 3 | 0 | 10 | 10 |
| 2019 2 | 0 | 14 | 14 |
| 2019 1 | 0 | 5 | 5 |
| 2018 12 | 0 | 19 | 19 |
| 2018 11 | 0 | 14 | 14 |
| 2018 10 | 0 | 20 | 20 |
| 2017 10 | 7 | 3 | 10 |
| 2017 9 | 12 | 1 | 13 |
| 2017 8 | 10 | 2 | 12 |
| 2017 7 | 15 | 6 | 21 |
| 2017 6 | 24 | 15 | 39 |
| 2017 5 | 20 | 17 | 37 |
| 2017 4 | 24 | 13 | 37 |
| 2017 3 | 27 | 14 | 41 |
| 2017 2 | 20 | 11 | 31 |
| 2016 1 | 9 | 6 | 15 |
| 2016 12 | 23 | 7 | 30 |
| 2016 11 | 23 | 8 | 31 |
| 2016 10 | 44 | 10 | 54 |
| 2016 9 | 30 | 8 | 38 |
| 2016 8 | 27 | 13 | 40 |
| 2016 7 | 22 | 8 | 30 |
| 2016 6 | 23 | 16 | 39 |
| 2016 5 | 20 | 6 | 26 |
| 2016 4 | 19 | 21 | 40 |
| 2016 3 | 17 | 13 | 30 |
| 2016 2 | 16 | 16 | 32 |
| 2015 1 | 22 | 19 | 41 |
| 2015 12 | 25 | 14 | 39 |
| 2015 11 | 22 | 14 | 36 |
| 2015 10 | 30 | 17 | 47 |
| 2015 9 | 31 | 10 | 41 |
| 2015 8 | 12 | 8 | 20 |
| 2015 7 | 14 | 12 | 26 |
| 2015 6 | 9 | 4 | 13 |
| 2015 5 | 23 | 12 | 35 |
| 2015 4 | 14 | 11 | 25 |
| 2015 3 | 21 | 6 | 27 |
| 2015 2 | 11 | 9 | 20 |
| 2015 1 | 23 | 6 | 29 |
| 2014 12 | 27 | 6 | 33 |
| 2014 11 | 3 | 2 | 5 |
| 2014 10 | 1 | 1 | 2 |
| 2014 9 | 2 | 1 | 3 |
| 2014 8 | 4 | 1 | 5 |
| 2014 7 | 3 | 0 | 3 |
| 2014 6 | 2 | 2 | 4 |
| 2014 5 | 6 | 2 | 8 |
| 2013 6 | 1 | 0 | 1 |
| 2013 5 | 2 | 0 | 2 |
| 2011 12 | 568 | 0 | 568 |
Mostrar todo
